Wholeleaf targets 7,000 pharmacy outlets across seven Indian cities by end-2025
Cannabinoid-based pain therapeutics maker Wholeleaf is pushing pan-India, eyeing Bangalore, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa and Chennai. The brand plans to scale to 7,000 retail touchpoints via tie-ups with Apollo Pharmacy, Wellness Forever, Guardian and independent chemists, riding a projected 20-25% category CAGR.
What happened
Wholeleaf, a licensed cannabinoid-based pain therapeutics company, plans pan-India expansion across seven cities and aims to grow its retail footprint to 7,000
Key facts
- 7,000 outlets
- 20-25% CAGR
Why this matters
Wholeleaf's chain partnerships and first-mover scale in cannabinoid pain therapeutics make it a watch-list candidate for strategic investment or distribution alliances by larger pharma and wellness retailers seeking exposure to the emerging category.